Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy

Teresa Santantonio, E. Medda, C. Ferrari, P. Fabris, G. Cariti, M. Massari, S. Babudieri, M. Toti, R. Francavilla, F. Ancarani, G. Antonucci, G. Scotto, V. Di Marco, G. Pastore, T. Stroffolini

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Background. The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated. Methods. To evaluate current sources of hepatitis C virus (HCV) transmission in Italy and to assess the rate of and factors associated with chronic infection, we enrolled 214 consecutive patients with newly acquired hepatitis C during 1999-2004. The patients were from 12 health care centers throughout the country, and they were followed up for a mean (± SD) period of 14 ± 15.8 months. Biochemical liver tests were performed, and HCV RNA levels were monitored. Results. A total of 146 patients (68%) had symptomatic disease. The most common risk factors for acquiring hepatitis C that were reported were intravenous drug use and medical procedures. The proportion of subjects with spontaneous resolution of infection was 36%. The average timespan from disease onset to HCV RNA clearance was 71 days (range, 27-173 days). In fact, 58 (80%) of 73 patients with self-limiting hepatitis experienced HCV RNA clearance within 3 months of disease onset. Multiple logistic regression analyses showed that none of the variables considered (including asymptomatic disease) were associated with increased risk of developing chronic hepatitis C. Conclusions. These findings underscore the importance of medical procedures as risk factors in the current spread of HCV infection in Italy. Because nearly all patients with acute, self-limiting hepatitis C-both symptomatic and asymptomatic-have spontaneous viral clearance within 3 months of disease onset, it seems reasonable to start treatment after this time period ends to avoid costly and useless treatment.

Original languageEnglish
Pages (from-to)1154-1159
Number of pages6
JournalClinical Infectious Diseases
Volume43
Issue number9
DOIs
Publication statusPublished - Nov 1 2006

Fingerprint

Hepatitis C
Hepacivirus
Italy
Virus Diseases
RNA
Infection
Asymptomatic Diseases
Chronic Hepatitis C
Hepatitis
Epidemiology
Logistic Models
Regression Analysis
Delivery of Health Care
Liver
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology

Cite this

Santantonio, T., Medda, E., Ferrari, C., Fabris, P., Cariti, G., Massari, M., ... Stroffolini, T. (2006). Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clinical Infectious Diseases, 43(9), 1154-1159. https://doi.org/10.1086/507640

Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. / Santantonio, Teresa; Medda, E.; Ferrari, C.; Fabris, P.; Cariti, G.; Massari, M.; Babudieri, S.; Toti, M.; Francavilla, R.; Ancarani, F.; Antonucci, G.; Scotto, G.; Di Marco, V.; Pastore, G.; Stroffolini, T.

In: Clinical Infectious Diseases, Vol. 43, No. 9, 01.11.2006, p. 1154-1159.

Research output: Contribution to journalArticle

Santantonio, T, Medda, E, Ferrari, C, Fabris, P, Cariti, G, Massari, M, Babudieri, S, Toti, M, Francavilla, R, Ancarani, F, Antonucci, G, Scotto, G, Di Marco, V, Pastore, G & Stroffolini, T 2006, 'Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy', Clinical Infectious Diseases, vol. 43, no. 9, pp. 1154-1159. https://doi.org/10.1086/507640
Santantonio, Teresa ; Medda, E. ; Ferrari, C. ; Fabris, P. ; Cariti, G. ; Massari, M. ; Babudieri, S. ; Toti, M. ; Francavilla, R. ; Ancarani, F. ; Antonucci, G. ; Scotto, G. ; Di Marco, V. ; Pastore, G. ; Stroffolini, T. / Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. In: Clinical Infectious Diseases. 2006 ; Vol. 43, No. 9. pp. 1154-1159.
@article{bd2eb9d96f674d89929be1b089672104,
title = "Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy",
abstract = "Background. The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated. Methods. To evaluate current sources of hepatitis C virus (HCV) transmission in Italy and to assess the rate of and factors associated with chronic infection, we enrolled 214 consecutive patients with newly acquired hepatitis C during 1999-2004. The patients were from 12 health care centers throughout the country, and they were followed up for a mean (± SD) period of 14 ± 15.8 months. Biochemical liver tests were performed, and HCV RNA levels were monitored. Results. A total of 146 patients (68{\%}) had symptomatic disease. The most common risk factors for acquiring hepatitis C that were reported were intravenous drug use and medical procedures. The proportion of subjects with spontaneous resolution of infection was 36{\%}. The average timespan from disease onset to HCV RNA clearance was 71 days (range, 27-173 days). In fact, 58 (80{\%}) of 73 patients with self-limiting hepatitis experienced HCV RNA clearance within 3 months of disease onset. Multiple logistic regression analyses showed that none of the variables considered (including asymptomatic disease) were associated with increased risk of developing chronic hepatitis C. Conclusions. These findings underscore the importance of medical procedures as risk factors in the current spread of HCV infection in Italy. Because nearly all patients with acute, self-limiting hepatitis C-both symptomatic and asymptomatic-have spontaneous viral clearance within 3 months of disease onset, it seems reasonable to start treatment after this time period ends to avoid costly and useless treatment.",
author = "Teresa Santantonio and E. Medda and C. Ferrari and P. Fabris and G. Cariti and M. Massari and S. Babudieri and M. Toti and R. Francavilla and F. Ancarani and G. Antonucci and G. Scotto and {Di Marco}, V. and G. Pastore and T. Stroffolini",
year = "2006",
month = "11",
day = "1",
doi = "10.1086/507640",
language = "English",
volume = "43",
pages = "1154--1159",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "NLM (Medline)",
number = "9",

}

TY - JOUR

T1 - Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy

AU - Santantonio, Teresa

AU - Medda, E.

AU - Ferrari, C.

AU - Fabris, P.

AU - Cariti, G.

AU - Massari, M.

AU - Babudieri, S.

AU - Toti, M.

AU - Francavilla, R.

AU - Ancarani, F.

AU - Antonucci, G.

AU - Scotto, G.

AU - Di Marco, V.

AU - Pastore, G.

AU - Stroffolini, T.

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Background. The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated. Methods. To evaluate current sources of hepatitis C virus (HCV) transmission in Italy and to assess the rate of and factors associated with chronic infection, we enrolled 214 consecutive patients with newly acquired hepatitis C during 1999-2004. The patients were from 12 health care centers throughout the country, and they were followed up for a mean (± SD) period of 14 ± 15.8 months. Biochemical liver tests were performed, and HCV RNA levels were monitored. Results. A total of 146 patients (68%) had symptomatic disease. The most common risk factors for acquiring hepatitis C that were reported were intravenous drug use and medical procedures. The proportion of subjects with spontaneous resolution of infection was 36%. The average timespan from disease onset to HCV RNA clearance was 71 days (range, 27-173 days). In fact, 58 (80%) of 73 patients with self-limiting hepatitis experienced HCV RNA clearance within 3 months of disease onset. Multiple logistic regression analyses showed that none of the variables considered (including asymptomatic disease) were associated with increased risk of developing chronic hepatitis C. Conclusions. These findings underscore the importance of medical procedures as risk factors in the current spread of HCV infection in Italy. Because nearly all patients with acute, self-limiting hepatitis C-both symptomatic and asymptomatic-have spontaneous viral clearance within 3 months of disease onset, it seems reasonable to start treatment after this time period ends to avoid costly and useless treatment.

AB - Background. The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated. Methods. To evaluate current sources of hepatitis C virus (HCV) transmission in Italy and to assess the rate of and factors associated with chronic infection, we enrolled 214 consecutive patients with newly acquired hepatitis C during 1999-2004. The patients were from 12 health care centers throughout the country, and they were followed up for a mean (± SD) period of 14 ± 15.8 months. Biochemical liver tests were performed, and HCV RNA levels were monitored. Results. A total of 146 patients (68%) had symptomatic disease. The most common risk factors for acquiring hepatitis C that were reported were intravenous drug use and medical procedures. The proportion of subjects with spontaneous resolution of infection was 36%. The average timespan from disease onset to HCV RNA clearance was 71 days (range, 27-173 days). In fact, 58 (80%) of 73 patients with self-limiting hepatitis experienced HCV RNA clearance within 3 months of disease onset. Multiple logistic regression analyses showed that none of the variables considered (including asymptomatic disease) were associated with increased risk of developing chronic hepatitis C. Conclusions. These findings underscore the importance of medical procedures as risk factors in the current spread of HCV infection in Italy. Because nearly all patients with acute, self-limiting hepatitis C-both symptomatic and asymptomatic-have spontaneous viral clearance within 3 months of disease onset, it seems reasonable to start treatment after this time period ends to avoid costly and useless treatment.

UR - http://www.scopus.com/inward/record.url?scp=33750117419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750117419&partnerID=8YFLogxK

U2 - 10.1086/507640

DO - 10.1086/507640

M3 - Article

VL - 43

SP - 1154

EP - 1159

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 9

ER -